Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C.E.R.A. Maintenance in Pre-dialysis Chronic Renal Anemia
NCT00517881Phase 3Terminated
- Sponsor
- Roche
- Start
- Jun 2007
- Primary completion
- Nov 2009
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease (CKD-A), sponsored by Roche. Primary endpoint: Percentage of Participants Maintaining Mean Hemoglobin Concentration Within +/- 1 g/dL of Reference and Within Target Range. Started Jun 2007; status: terminated.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT00517881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517881.